129 related articles for article (PubMed ID: 26743075)
21. Human papillomavirus type 16 L1/L2 DNA methylation shows weak association with cervical disease grade in young women.
Bryant D; Hibbitts S; Almonte M; Tristram A; Fiander A; Powell N
J Clin Virol; 2015 May; 66():66-71. PubMed ID: 25866341
[TBL] [Abstract][Full Text] [Related]
22. Breaking the DNA damage response to improve cervical cancer treatment.
Wieringa HW; van der Zee AG; de Vries EG; van Vugt MA
Cancer Treat Rev; 2016 Jan; 42():30-40. PubMed ID: 26643553
[TBL] [Abstract][Full Text] [Related]
23. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus and cervical cancer.
Crook T; Farthing A
Br J Hosp Med; 1993 Jan 20-Feb 2; 49(2):131-2. PubMed ID: 8382097
[TBL] [Abstract][Full Text] [Related]
25. Assessment of the HPV DNA methylation status in cervical lesions.
Kalantari M; Bernard HU
Methods Mol Biol; 2015; 1249():267-80. PubMed ID: 25348313
[TBL] [Abstract][Full Text] [Related]
26. The role of ADCYAP1, adenylate cyclase activating polypeptide 1, as a methylation biomarker for the early detection of cervical cancer.
Jung S; Yi L; Jeong D; Kim J; An S; Oh TJ; Kim CH; Kim CJ; Yang Y; Kim KI; Lim JS; Lee MS
Oncol Rep; 2011 Jan; 25(1):245-52. PubMed ID: 21109983
[TBL] [Abstract][Full Text] [Related]
27. CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients.
Widschwendter A; Ivarsson L; Blassnig A; Müller HM; Fiegl H; Wiedemair A; Müller-Holzner E; Goebel G; Marth C; Widschwendter M
Int J Cancer; 2004 Mar; 109(2):163-6. PubMed ID: 14750164
[TBL] [Abstract][Full Text] [Related]
28. Specific type epigenetic changes in cervical cancers.
Zhao S
Methods Mol Biol; 2015; 1238():733-49. PubMed ID: 25421689
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation changes in cervical cancers.
Lu Q; Ma D; Zhao S
Methods Mol Biol; 2012; 863():155-76. PubMed ID: 22359292
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
[TBL] [Abstract][Full Text] [Related]
31. Epigenetics of cervical cancer. An overview and therapeutic perspectives.
Dueñas-González A; Lizano M; Candelaria M; Cetina L; Arce C; Cervera E
Mol Cancer; 2005 Oct; 4():38. PubMed ID: 16248899
[TBL] [Abstract][Full Text] [Related]
32. Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer.
Li X
BMC Cancer; 2017 Apr; 17(1):252. PubMed ID: 28390392
[TBL] [Abstract][Full Text] [Related]
33. microRNAs: New prognostic, diagnostic, and therapeutic biomarkers in cervical cancer.
Nahand JS; Taghizadeh-Boroujeni S; Karimzadeh M; Borran S; Pourhanifeh MH; Moghoofei M; Bokharaei-Salim F; Karampoor S; Jafari A; Asemi Z; Tbibzadeh A; Namdar A; Mirzaei H
J Cell Physiol; 2019 Aug; 234(10):17064-17099. PubMed ID: 30891784
[TBL] [Abstract][Full Text] [Related]
34. DNA methylation profiles in cancer diagnosis and therapeutics.
Pan Y; Liu G; Zhou F; Su B; Li Y
Clin Exp Med; 2018 Feb; 18(1):1-14. PubMed ID: 28752221
[TBL] [Abstract][Full Text] [Related]
35. Autophagy in cervical cancer: an emerging therapeutic target.
Pandey S; Chandravati
Asian Pac J Cancer Prev; 2012; 13(10):4867-71. PubMed ID: 23244072
[TBL] [Abstract][Full Text] [Related]
36. What will it take to obtain DNA methylation markers for early cervical cancer detection?
Nephew KP
Gynecol Oncol; 2009 Feb; 112(2):291-2. PubMed ID: 19150524
[No Abstract] [Full Text] [Related]
37. DNA Methylation and Hydroxymethylation in Cervical Cancer: Diagnosis, Prognosis and Treatment.
Zhu H; Zhu H; Tian M; Wang D; He J; Xu T
Front Genet; 2020; 11():347. PubMed ID: 32328088
[TBL] [Abstract][Full Text] [Related]
38. The role of HPV-induced epigenetic changes in cervical carcinogenesis (Review).
Da Silva MLR; De Albuquerque BHDR; Allyrio TAMF; De Almeida VD; Cobucci RNO; Bezerra FL; Andrade VS; Lanza DCF; De Azevedo JCV; De Araújo JMG; Fernandes JV
Biomed Rep; 2021 Jul; 15(1):60. PubMed ID: 34094536
[TBL] [Abstract][Full Text] [Related]
39. Molecular landscape of recurrent cervical cancer.
Adiga D; Eswaran S; Pandey D; Sharan K; Kabekkodu SP
Crit Rev Oncol Hematol; 2021 Jan; 157():103178. PubMed ID: 33279812
[TBL] [Abstract][Full Text] [Related]
40. Phytochemicals in cervical cancer: an epigenetic overview.
Elzeiny N; Sayed Shafei AE; Wagih S; Saad M; Sayed D; Salem EY; Wael M; Ellackany R; Matboli M
Epigenomics; 2023 Sep; 15(18):941-959. PubMed ID: 37916277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
